Page last updated: 2024-10-19

lipoamide and Diabetic Nephropathies

lipoamide has been researched along with Diabetic Nephropathies in 1 studies

Lipozyme: lipase from Rhizomucor miehei immobilized on anion exchange resin

Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhang, HF1
Liu, HM1
Xiang, JY1
Zhou, XC1
Wang, D1
Chen, RY1
Tan, WL1
Liang, LQ1
Liu, LL1
Shi, MJ1
Zhang, F1
Xiao, Y1
Zhou, YX1
Zhang, T1
Tang, L1
Guo, B1
Wang, YY1

Other Studies

1 other study available for lipoamide and Diabetic Nephropathies

ArticleYear
Alpha lipoamide inhibits diabetic kidney fibrosis via improving mitochondrial function and regulating RXRα expression and activation.
    Acta pharmacologica Sinica, 2023, Volume: 44, Issue:5

    Topics: Animals; beta Catenin; Cystic Fibrosis Transmembrane Conductance Regulator; Diabetes Mellitus, Type

2023